Word: words
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
...right, of course, about the third alternative, and a very sensible one it is--working out some system of fooling the grader, although I think I should prefer the word "impressing." We admit to being impressionable, but not to being hyper-credulous simps. His first two tactics for system-beating, his Vague Generalities and Artful Equivocations, seem to presume the latter, and are only going to convince Crimson-reading graders (there are a few and we tell our friends) that the time has come to tighten the screws just a bit more...
...tenure review in their home departments. A letter to me and my advisor, Professor Charles Nesson of Harvard Law School, of Oct. 21, 1998, from Professor Roderick MacFarquhar, chair of the Department of Government, explains that in the composition of the ad hoc committee, "The Dean has the final word, presumably to ensure that no Department can pack the committee to ensure success." Harvard's own tenure review procedures require that the president, so far from relying on the objectivity of tenured faculty, must consult with scholars from other departments and from outside the university who are "chosen for their...
...disclose his or her identity, has become concerned for my future. But I can't help wondering about the quality of concern, to say nothing of the purported access to my inner state, inasmuch as no member of the University administration has uttered so much as a single word to me in connection to my appeal...
...Louis, Mo., and at the Sanger Centre passed a new milestone by decoding the first animal genome, that of a tiny roundworm, Caenorhabditis elegans. At 97 million letters, C. elegans' genome is by far the most sophisticated ever sequenced. But if Venter's newly formed Celera (derived from the word celerity, which means swiftness) can pull it off, his proposal to shotgun the entire 3 billion-letter human genome in three years will make the roundworm's DNA look downright puny...
...cancer research at Merck. "We were on the verge of abandoning the project." Then Oliff's team realized something critical: the ras protein can't do its job until it has been activated by another enzyme called a farnesyl transferase. Maybe that would make a better target? Early word is that it does, but Merck won't publish the findings from its first human trials until sometime next year...